Patent · US Active

Compositions and methods of nucleic acid-targeting nucleic acids

US9260752B1 · kind B1 · utility

66Cited by
26References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 12, 2014
Grant dateFeb 16, 2016
Priority date
Expiry dateMar 12, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This disclosure provides for compositions and methods for the use of nucleic acid-targeting nucleic acids and complexes thereof. Genome engineering can refer to altering the genome by deleting, inserting, mutating, or substituting specific nucleic acid sequences. The altering can be gene or location specific. Genome engineering can use nucleases to cut a nucleic acid thereby generating a site for the alteration. Engineering of non-genomic nucleic acid is also contemplated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.